Bio: Roger A. Dixon (University of Alberta) is Professor of Psychology (Science) and a member of the Neuroscience and Mental Health Institute. He has held previous appointments at Max Planck Institute (Berlin) and University of Victoria (Canada), as well as several international guest positions (eg. Karolinska Institutet, Stockholm; Stanford Centre for Advanced Studies, California). His recent recognitions include a Canada Research Chair (Tier 1, 2003-2010, 2010-2017), the 2013-14 Baltes Award for Distinguished Career Research in Aging (from the American Psychological Association), and two U.S. National Institutes of Health (NIH) MERIT Awards. His research is conducted primarily in the context of two large-scale national and international projects. First, he is the PI and Director of the Victoria Longitudinal Study, which has been funded continuously for over 25 years by NIH and other sources and partners. It is a large-scale, multi-cohort, epidemiological study of neurocognitive, biological, biomedical, genetic, environmental, lifestyle, and functional changes affecting neurocognitive aging. Second, he is a PI of the Canadian Consortium on Neurodegeneration in Aging, a multi-disciplinary nation-wide investigation of multiple neurodegenerative diseases. The CCNA is funded by CIHR and partners and deploys cutting edge technologies in the domains of biomarkers, neuroimaging, genetic, neurocognitive, intervention, and clinical approaches to understanding Alzheimer’s disease and related dementias. Current research emphases include examining (1) dynamic, interactive, and synergistic functions of risk, protective, and resilience biomarkers representing multiple domains of brain aging and dementia, (2) how these biomarkers influence preclinical trajectories, transitions and clinical outcomes in healthy, normal, impaired, and neurodegenerative changes, and (3) omics-based biomarker discovery, validation, and translation in neurodegenerative disease.